Turn Therapeutics
TTRX
29 hedge funds and large institutions have $8.48M invested in Turn Therapeutics in 2026 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
474% more capital invested
Capital invested by funds: $1.48M → $8.48M (+$7.01M)
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
45% more funds holding
Funds holding: 20 → 29 (+9)
2.31% more ownership
Funds ownership: 1.57% → 3.88% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SW
SteelPeak Wealth
Woodland Hills,
California
|
+$1.16M |
| 2 |
IC
IEQ Capital
Foster City,
California
|
+$1.06M |
| 3 |
BlackRock
New York
|
+$179K |
| 4 |
DI
DDFG Inc
Thousand Oaks,
California
|
+$173K |
| 5 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
+$151K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$63.1K |
| 2 |
Millennium Management
New York
|
-$42.8K |
| 3 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$32K |
| 4 |
LPL Financial
San Diego,
California
|
-$13.9K |
TTRX Hedge Fund Activity: Q2 2026 in Review
29 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Turn Therapeutics (TTRX) for Q2 2026, worth a combined $8.48M — up 474% from $1.48M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TTRX positions and 2 closed out — a net gain of 9 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was SteelPeak Wealth, opening a new position worth an estimated $1.16M. The largest seller was XTX Topco, exiting entirely with an estimated $63.1K sold.
- 29 institutional investors held Turn Therapeutics (TTRX) as of Q2 2026, up from 20 in Q1 2026.
- Funds reported $8.48M of Turn Therapeutics stock for Q2 2026, up 474% quarter-over-quarter.
- 11 funds opened new Turn Therapeutics positions in Q2 2026 and 2 closed out, a net change of +9 holders.
- The largest Turn Therapeutics buyer in Q2 2026 was SteelPeak Wealth, an estimated $1.16M added.
- The largest Turn Therapeutics seller in Q2 2026 was XTX Topco, an estimated $63.1K sold.
Based on aggregated 13F filings for Q2 2026.